Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Safety of Pressurized Intraosseous Blood Infusion Strategies in a Swine Model of Hemorrhagic Shock.

Auten JD, McEvoy CS, Roszko PJ, Polk TM, Kachur RE, Kemp JD, Natarajan R, Zarow GJ.

J Surg Res. 2019 Oct 7;246:190-199. doi: 10.1016/j.jss.2019.09.005. [Epub ahead of print]

PMID:
31600648
2.

A Pilot Study of Four Intraosseous Blood Transfusion Strategies.

Auten JD, Mclean JB, Kemp JD, Roszko PJ, Fortner GA, Krepela AL, Walchak AC, Walker CM, Deaton TG, Fishback JE.

J Spec Oper Med. Fall 2018;18(3):50-56.

PMID:
30222837
3.

Comparison of Body Composition Measurements in Lean Female Athletes.

Houska CL, Kemp JD, Niles JS, Morgan AL, Tucker RM, Ludy MJ.

Int J Exerc Sci. 2018 May 1;11(4):417-424. eCollection 2018.

4.

Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. 1991.

Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K.

J Immunol. 2012 Oct 1;189(7):3271-83. No abstract available.

5.

Burnout in medical students: examining the prevalence and associated factors.

Santen SA, Holt DB, Kemp JD, Hemphill RR.

South Med J. 2010 Aug;103(8):758-63. doi: 10.1097/SMJ.0b013e3181e6d6d4.

PMID:
20622724
6.

Xanthogranulomatous reaction to a ruptured galactocele.

Adams EG, Kemp JD, Holcomb KZ, Sperling LC.

J Cutan Pathol. 2010 Sep;37(9):973-6. doi: 10.1111/j.1600-0560.2010.01535.x. Epub 2010 Feb 25.

PMID:
20202042
7.

2+ HER-2/neu IHC results: positively equivocal.

Kemp JD, Royer MC.

J Cutan Pathol. 2010 Aug;37(8):915; author reply 916. doi: 10.1111/j.1600-0560.2009.01478.x. Epub 2009 Nov 18. No abstract available.

PMID:
19922485
8.

Enhancing transfusion safety with an innovative bar-code-based tracking system.

Askeland RW, McGrane SP, Reifert DR, Kemp JD.

Healthc Q. 2009;12 Spec No Patient:85-9.

9.

The curious case of Ashley X.

Kirschner KL, Diekema D, Lantos J, Kemp JD, Doyle E, Mukherjee D, Schalick WO 3rd.

PM R. 2009 Apr;1(4):371-8. doi: 10.1016/j.pmrj.2009.03.006. No abstract available.

PMID:
19627921
10.

Genetic analysis of a novel Xylella fastidiosa subspecies found in the southwestern United States.

Randall JJ, Goldberg NP, Kemp JD, Radionenko M, French JM, Olsen MW, Hanson SF.

Appl Environ Microbiol. 2009 Sep;75(17):5631-8. doi: 10.1128/AEM.00609-09. Epub 2009 Jul 6.

11.

Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer.

Bernstein WB, Kemp JD, Kim GS, Johnson VV.

J Clin Oncol. 2008 Jul 1;26(19):3281-4. doi: 10.1200/JCO.2008.16.4533. No abstract available.

PMID:
18591564
12.

Improving transfusion safety: implementation of a comprehensive computerized bar code-based tracking system for detecting and preventing errors.

Askeland RW, McGrane S, Levitt JS, Dane SK, Greene DL, Vandeberg JA, Walker K, Porcella A, Herwaldt LA, Carmen LT, Kemp JD.

Transfusion. 2008 Jul;48(7):1308-17. doi: 10.1111/j.1537-2995.2008.01668.x. Epub 2008 Mar 13.

PMID:
18346018
13.

A Web-based database for pathology faculty effort reporting.

Dee FR, Haugen TH, Wynn PA, Leaven TC, Kemp JD, Cohen MB.

Hum Pathol. 2008 Apr;39(4):489-97. doi: 10.1016/j.humpath.2007.10.033.

PMID:
18342660
14.

A comparative labor productivity analysis of blood collection centers.

Bell AM, Kemp JD, Raife TJ.

Transfusion. 2008 Feb;48(2):258-63. Epub 2007 Nov 13.

PMID:
18005326
15.

Disability: a changing landscape.

Kemp JD.

Assist Technol. 2006 Fall;18(2):205-11. No abstract available.

PMID:
17236479
16.

Rehabilitation Medicine Summit: Building Research Capacity--executive summary.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

Assist Technol. 2006 Spring;18(1):2-14.

PMID:
16796237
17.

Rehabilitation medicine summit: building research capacity.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham HP, Roth EJ, Tate DG.

Top Stroke Rehabil. 2005 Fall;12(4):68-80.

PMID:
16698738
18.

Rehabilitation Medicine Summit: Building Research Capacity-Executive Summary.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

J Rehabil Res Dev. 2005 Nov-Dec;42(6):x-xxiii.

19.

Rehabilitation Medicine Summit: Building Research Capacity: executive summary.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

Am J Occup Ther. 2006 Mar-Apr;60(2):165-76.

PMID:
16596920
20.

Rehabilitation Medicine Summit: building research capacity.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

J Spinal Cord Med. 2006;29(1):70-81.

21.

Rehabilitation medicine summit: building research capacity (executive summary).

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

Am J Speech Lang Pathol. 2006 Feb;15(1):3-14.

PMID:
16533088
22.

Rehabilitation medicine summit: building research capacity.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

J Head Trauma Rehabil. 2006 Jan-Feb;21(1):1-7.

PMID:
16456387
23.

Rehabilitation Medicine Summit: Building Research Capacity--executive summary.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

Phys Ther. 2006 Feb;86(2):285-98; discussion 299-300.

PMID:
16445342
24.

Rehabilitation medicine summit: building research capacity. Executive summary.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

Arch Phys Med Rehabil. 2006 Jan;87(1):148-52.

PMID:
16401455
25.

Rehabilitation medicine summit: building research capacity.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tated DG.

Disabil Rehabil. 2006 Jan 15;28(1):71-5. No abstract available.

PMID:
16393836
26.

Rehabilitation medicine summit: building research capacity executive summary.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

J Neuroeng Rehabil. 2006 Jan 3;3:1.

27.

Rehabilitation Medicine Summit: building research capacity.

Frontera WR, Fuhrer MJ, Jette AM, Chan L, Cooper RA, Duncan PW, Kemp JD, Ottenbacher KJ, Peckham PH, Roth EJ, Tate DG.

Am J Phys Med Rehabil. 2005 Dec;84(12):913-7.

PMID:
16327406
28.

A simple, focused, computerized query to detect overutilization of laboratory tests.

Weydert JA, Nobbs ND, Feld R, Kemp JD.

Arch Pathol Lab Med. 2005 Sep;129(9):1141-3.

PMID:
16119987
29.

BiP and zein binding domains within the delta zein protein.

Randall JJ, Sutton DW, Hanson SF, Kemp JD.

Planta. 2005 Jul;221(5):656-66. Epub 2005 Feb 23.

PMID:
15726401
30.

PhD graduate training programs in pathology: 2003 report from the American Society for Investigative Pathology workshop on pathology graduate education.

Kemp JD, Bowser R; American Society for Investigative Pathology workshop.

Hum Pathol. 2004 Jul;35(7):785-9. Review.

PMID:
15257540
31.

Fluorescent amplified fragment length polymorphism analysis of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis isolates.

Hill KK, Ticknor LO, Okinaka RT, Asay M, Blair H, Bliss KA, Laker M, Pardington PE, Richardson AP, Tonks M, Beecher DJ, Kemp JD, Kolstø AB, Wong AC, Keim P, Jackson PJ.

Appl Environ Microbiol. 2004 Feb;70(2):1068-80.

32.

Noise reduction in a launch vehicle fairing using actively tuned loudspeakers.

Kemp JD, Clark RL.

J Acoust Soc Am. 2003 Apr;113(4 Pt 1):1986-94.

PMID:
12703709
33.

Multivalent metal-induced iron acquisition from transferrin and lactoferrin by myeloid cells.

Olakanmi O, Rasmussen GT, Lewis TS, Stokes JB, Kemp JD, Britigan BE.

J Immunol. 2002 Aug 15;169(4):2076-84.

34.

Identification of a signal peptide for oryzacystatin-I.

Womack JS, Randall J, Kemp JD.

Planta. 2000 Apr;210(5):844-7.

PMID:
10805458
35.

Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro.

Kovár J, Kemp JD.

In Vitro Cell Dev Biol Anim. 2000 Mar;36(3):151-2. No abstract available.

PMID:
10777053
37.

Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13.

Kovar J, Stunz LL, Stewart BC, Kriegerbeckova K, Ashman RF, Kemp JD.

Pathobiology. 1997;65(2):61-8.

PMID:
9253029
38.

A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer.

Dreicer R, Kemp JD, Stegink LD, Cardillo T, Davis CS, Forest PK, See WA.

Cancer Invest. 1997;15(4):311-7.

PMID:
9246151
39.
40.

Cell Ablation Reveals That Expression from the Phaseolin Promoter Is Confined to Embryogenesis and Microsporogenesis.

Van Der Geest A, Frisch DA, Kemp JD, Hall TC.

Plant Physiol. 1995 Dec;109(4):1151-1158.

41.
43.

Accumulation of 15-Kilodalton Zein in Novel Protein Bodies in Transgenic Tobacco.

Bagga S, Adams H, Kemp JD, Sengupta-Gopalan C.

Plant Physiol. 1995 Jan;107(1):13-23.

44.
45.

Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia.

Raife TJ, Lager DJ, Kemp JD, Dick FR.

Am J Clin Pathol. 1994 Mar;101(3):296-9.

PMID:
7510927
46.
47.

Photoaffinity labeling of acyl-CoA oxidase with 12-azidooleoyl-CoA and 12-[(4-azidosalicyl)amino]dodecanoyl-CoA.

Rajasekharan R, Marians RC, Shockey JM, Kemp JD.

Biochemistry. 1993 Nov 23;32(46):12386-91.

PMID:
8241127
48.

Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease = report of six cases.

Bonsib SM, Goeken JA, Kemp JD, Chandran P, Shadur C, Wilson L.

Mod Pathol. 1993 Sep;6(5):526-30.

PMID:
8248108
49.

The 3G11+ antigen, a marker for murine CD4+ TH1 lymphocytes, is a ganglioside.

Greer JM, Koerner TA, Hayakawa K, Hardy RR, Kemp JD.

Glycobiology. 1993 Aug;3(4):391-401.

PMID:
7691279
50.

The role of iron and iron binding proteins in lymphocyte physiology and pathology.

Kemp JD.

J Clin Immunol. 1993 Mar;13(2):81-92. Review.

PMID:
8320312

Supplemental Content

Support Center